Cancer News
Mandatory Extended RAS Testing for mCRC

ASCO Calls for Appropriate & Accurate Data Transparency

'Dying in America' IOM Report Calls for Major Reform

PET-CT Better Than CT in Follicular Lymphoma

What's Hot at ESMO 2014
Exercise can enhance tumor-shrinking effects of chemotherapy

More accurate treatment, greater patient comfort provided by new radiosurgery technology

Preserved mobility in malignant spinal cord compression

Cancer resistance may one day be treated with epigenetic drugs

New molecule 'allows umbilical cord stem cells to multiply'
Family Squabbles Can Derail Recovery From Cancer Surgery

Urine Test for HPV Works Well, Analysis Finds

New Gene Variants for Prostate Cancer Identified

Golden Retriever Study Sniffs for Cancer Clues

Can Prediabetes Raise Risk of Certain Cancers?
Special Recognition for Jonsson Comprehensive Cancer Center at Avon Walk for Breast Cancer

FDA Approves Game-Changing Melanoma Drug that Turns on Immune System to Fight Deadly Cancers

Vault Nanoparticles Engineered at UCLA Show Promise for Cancer Treatment

JCCC Scientist Honored with Prestigious Biomedical Science Award

PROFILE: Dr. Denis Evseenko—Harnessing the Regenerative Power of Stem Cells in Cancer Research
A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study)

Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines